Published in Br J Pharmacol on November 27, 2016
Principles of pharmacological research of nutraceuticals. Br J Pharmacol (2017) 0.75
Rice Bran and Probiotics Alter the Porcine Large Intestine and Serum Metabolomes for Protection against Human Rotavirus Diarrhea. Front Microbiol (2017) 0.75
Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (1992) 16.31
Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet (1962) 13.72
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res (2015) 10.66
Diet and the evolution of human amylase gene copy number variation. Nat Genet (2007) 8.64
Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol (2008) 8.51
Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev (2012) 8.31
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol (1995) 8.09
Evolution, consequences and future of plant and animal domestication. Nature (2002) 7.44
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun (1995) 6.55
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA (2015) 6.37
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol (2015) 5.96
Role of endogenous cannabinoids in synaptic signaling. Physiol Rev (2003) 5.70
The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother (2002) 5.58
The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol (2015) 4.28
The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol (2007) 4.22
Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr (2011) 4.03
Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov (2008) 3.93
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science (2011) 3.48
Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med (1985) 3.29
Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes (2008) 2.68
Pharmacological actions of cannabinoids. Handb Exp Pharmacol (2005) 2.56
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci (2010) 2.37
Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc Natl Acad Sci U S A (2005) 2.35
Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol (2009) 2.23
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat Neurosci (2011) 2.17
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol (2007) 2.08
Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. Gastroenterology (2012) 2.01
Food as medicine and medicine as food. An adaptive framework for the interpretation of plant utilization among the Hausa of Northern Nigeria. Soc Sci Med (1982) 1.98
Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A (2008) 1.97
Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem (2009) 1.91
Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications. Eur J Clin Nutr (1997) 1.88
The Concise Guide to PHARMACOLOGY 2015/16: Voltage-gated ion channels. Br J Pharmacol (2015) 1.88
Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther (2010) 1.81
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem (2005) 1.78
The enigmatic pharmacology of GPR55. Trends Pharmacol Sci (2009) 1.68
Meat-adaptive genes and the evolution of slower aging in humans. Q Rev Biol (2004) 1.67
The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors. Br J Pharmacol (2015) 1.62
The endocannabinoid system in obesity and type 2 diabetes. Diabetologia (2008) 1.61
Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res (2011) 1.60
Small molecules that regulate lifespan: evidence for xenohormesis. Mol Microbiol (2004) 1.59
Obesity: evolution of a symptom of affluence. Neth J Med (2011) 1.52
Xenohormesis: sensing the chemical cues of other species. Cell (2008) 1.50
Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv (2015) 1.49
Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem (2010) 1.49
Bimodal control of stimulated food intake by the endocannabinoid system. Nat Neurosci (2010) 1.49
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol (2014) 1.47
Natural products--a simple model to explain chemical diversity. Nat Prod Rep (2003) 1.47
Mechanisms of stress in the brain. Nat Neurosci (2015) 1.47
Greenlandic Inuit show genetic signatures of diet and climate adaptation. Science (2015) 1.46
A runner's high depends on cannabinoid receptors in mice. Proc Natl Acad Sci U S A (2015) 1.45
Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci U S A (2001) 1.41
Δ⁹-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood. J Leukoc Biol (2014) 1.41
Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats. J Neurosci (2008) 1.37
An analysis of the food plants and drug plants of native North America. J Ethnopharmacol (1996) 1.35
Comparative primate energetics and hominid evolution. Am J Phys Anthropol (1997) 1.32
The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels. Br J Pharmacol (2015) 1.30
Cardiovascular disease risk factors and diet of Fulani pastoralists of northern Nigeria. Am J Clin Nutr (2001) 1.29
GPR55: a new member of the cannabinoid receptor clan? Br J Pharmacol (2007) 1.27
The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic. Eur J Clin Nutr (2002) 1.26
The peripheral cannabinoid receptor knockout mice: an update. Br J Pharmacol (2007) 1.25
Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. J Acad Nutr Diet (2012) 1.25
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One (2009) 1.25
Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci (2015) 1.25
Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr (1999) 1.22
Evolutionary origins of the endocannabinoid system. Gene (2006) 1.21
The case for peripheral CB₁ receptor blockade in the treatment of visceral obesity and its cardiometabolic complications. Br J Pharmacol (2011) 1.21
The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol (2011) 1.21
Why do cannabinoid receptors have more than one endogenous ligand? Philos Trans R Soc Lond B Biol Sci (2012) 1.17
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int J Obes (Lond) (2006) 1.16
The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation. Int J Obes (Lond) (2009) 1.13
Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids. PLoS One (2012) 1.13
Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). Public Health Nutr (2007) 1.09
Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. J Neuroimmune Pharmacol (2009) 1.09
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy. Diabetes (2011) 1.08
Neurobiological Interactions Between Stress and the Endocannabinoid System. Neuropsychopharmacology (2015) 1.08
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. Carcinogenesis (2010) 1.08
The thrifty lipids: endocannabinoids and the neural control of energy conservation. Trends Neurosci (2012) 1.08
Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. J Lipid Res (2010) 1.08
Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vascul Pharmacol (2012) 1.07
Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br J Pharmacol (2007) 1.07
The brain tracks the energetic value in food images. Neuroimage (2008) 1.06
Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'. J Exp Biol (2012) 1.05
β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway. Am J Pathol (2011) 1.05
Metabolic effects of chronic cannabis smoking. Diabetes Care (2013) 1.04
Phytocannabinoids beyond the Cannabis plant - do they exist? Br J Pharmacol (2010) 1.03
Characterization of an arachidonic acid-deficient (Fads1 knockout) mouse model. J Lipid Res (2012) 1.03
The major central endocannabinoid directly acts at GABA(A) receptors. Proc Natl Acad Sci U S A (2011) 1.02
Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr Metab (Lond) (2011) 1.02
Archaeobotanical study of ancient food and cereal remains at the Astana Cemeteries, Xinjiang, China. PLoS One (2012) 1.02
Role of cannabinoid CB2 receptors in glucose homeostasis in rats. Eur J Pharmacol (2007) 1.01
Discovery of potent and reversible monoacylglycerol lipase inhibitors. Chem Biol (2009) 1.01
New insights on the role of the endocannabinoid system in the regulation of energy balance. Int J Obes (Lond) (2015) 1.00
Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance. Diabetologia (2011) 1.00
An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. Nutrients (2016) 1.00
Botanical drugs, synergy, and network pharmacology: forth and back to intelligent mixtures. Planta Med (2011) 0.98
The gourmet ape: evolution and human food preferences. Am J Clin Nutr (2009) 0.98
Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle. Rev Endocr Metab Disord (2011) 0.97
Molecular mechanisms of fat preference and overeating. Ann N Y Acad Sci (2008) 0.96
Spices: the savory and beneficial science of pungency. Rev Physiol Biochem Pharmacol (2013) 0.96
Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J Biol Chem (2012) 0.96